Evommune, Inc. (EVMN) Institutional Ownership Changes & 13F Activity
Evommune, Inc. (EVMN). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Point72 Asset Management, L.P., Vestal Point Capital, Lp, Price T Rowe Associates Inc, Verition Fund Management Llc, and Balyasny Asset Management L.P..
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +26,096 | +203.7% | 38,908 | $517.09K | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +10,724 | — | 10,724 | $142.52K | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Buy | +11,089 | +1942.0% | 11,660 | $154.96K | Q2 2026 | Aug 24, 2026 |
| Cantor Fitzgerald, L. P. | Buy | +51,796 | — | 51,796 | $688.37K | Q2 2026 | Aug 19, 2026 |
| Point72 Asset Management, L.P. | Buy | +1,398,472 | +3823.4% | 1,435,049 | $19.07M | Q2 2026 | Aug 14, 2026 |
| Vestal Point Capital, Lp | Buy | +1,000,000 | — | 1,000,000 | $13.29M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +821,918 | +73.4% | 1,940,939 | $25.80M | Q2 2026 | Aug 14, 2026 |
| Verition Fund Management Llc | Sell | -506,055 | -92.0% | 43,936 | $583.91K | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Buy | +457,015 | — | 457,015 | $6.07M | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +232,440 | — | 232,440 | $3.09M | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +176,752 | +8935.9% | 178,730 | $2.38M | Q2 2026 | Aug 14, 2026 |
| Orbimed Advisors Llc | Buy | +161,000 | — | 161,000 | $2.14M | Q2 2026 | Aug 14, 2026 |
| Eversept Partners, Lp | Buy | +119,780 | +219.1% | 174,460 | $2.32M | Q2 2026 | Aug 14, 2026 |
| Lmr Partners Llp | Buy | +118,436 | — | 118,436 | $1.57M | Q2 2026 | Aug 14, 2026 |
| Longaeva Partners L.P. | Buy | +116,611 | — | 116,611 | $1.55M | Q2 2026 | Aug 14, 2026 |
| Defilade Capital Management, L.P. | Buy | +114,556 | +16.9% | 793,145 | $10.54M | Q2 2026 | Aug 14, 2026 |
| Holocene Advisors, Lp | Buy | +111,132 | — | 111,132 | $1.48M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +87,018 | — | 87,018 | $1.16M | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Sell | -80,027 | -43.5% | 104,035 | $1.38M | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Sell | -78,686 | -83.8% | 15,227 | $202.37K | Q2 2026 | Aug 14, 2026 |
| Avidity Partners Management Lp | Buy | +75,000 | — | 75,000 | $996.75K | Q2 2026 | Aug 14, 2026 |
| Seven Grand Managers, Llc | Sell | -74,102 | -45.0% | 90,568 | $1.20M | Q2 2026 | Aug 14, 2026 |
| Nextbio Capital Management Lp | Sell | -65,000 | -35.3% | 119,063 | $1.58M | Q2 2026 | Aug 14, 2026 |
| Sphera Funds Management Ltd. | Sell | -55,602 | -71.1% | 22,632 | $300.78K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +48,654 | +404.1% | 60,694 | $806.62K | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Buy | +47,702 | — | 47,702 | $633.96K | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +38,672 | +25.1% | 192,995 | $2.56M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +38,124 | +40.2% | 133,072 | $1.77M | Q2 2026 | Aug 14, 2026 |
| Freestone Grove Partners Lp | Sell | -30,963 | -9.2% | 306,328 | $4.07M | Q2 2026 | Aug 14, 2026 |
| Caption Management, Llc | Buy | +30,581 | — | 30,581 | $406.42K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about EVMN activity
Which institutional owners are buying EVMN?
Institutional owners buying EVMN include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in EVMN activity?
"Buy" means an investor increased their reported position in EVMN compared to the prior reporting period. This reflects growing exposure to Evommune, Inc. (EVMN) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in EVMN increasing?
Institutional interest in EVMN can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.